A previous study demonstrated that SUMO1 is up-regulated in human liver tumor tissues and hepatoma cell lines and that the knockdown of SUMO1 leads to an increase in the S to G2 phase ratio and the inhibition of SMMC7721 cell proliferation [3]. This evidence concerns the gene SUMO1 and hepatocellular carcinoma.